Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4585-4589

  Spugnini, Enrico P ^a   Vincenzi, Bruno ^b   Baldi, Feliciano ^c   Citro, Gennaro ^a   Baldi, Alfonso ^a,c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biphasic pulses; Bleomycin; Dog; Electroporation; Mast cell

Indexed keywords

BLEOMYCIN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; ELECTROCHEMOTHERAPY; ERYTHEMA; FEMALE; HISTOPATHOLOGY; MALE; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; ELECTRIC STIMULATION THERAPY; FEMALE; MALE; MASTOCYTOMA; RECURRENCE;

EID: 33845932808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dorn CR, Taylor DO, Schneider R, Hibbard HH and Klauber MR: Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40: 307-318, 1968.
2. Tam TR and Macy DW: Canine mast cell tumors. Comp Cont Educ Pract Vet 3: 869-878, 1981.
3. Macy DW: Canine and feline mast cell tumors: biologic behavior, diagnosis and therapy. Semin Vet Med Surg (Small Anim) 1: 72-83, 1986.
4. Thamm DH and Vail DM: Mast cell tumors. In: Small Animal Clinical Oncology. Withrow SJ, MacEwen EG (eds.), 3rd Edition, Philadelphia, PA: WB Saunders Co., pp. 261-282, 2001.
5. Bostock DE: The prognosis following surgical removal removal of mastocytomas in dogs. J Sm Anim Pract 14: 27-40, 1973.
6. Patnaik AK, Ehler WY and MacEwen EG: Canine cutaneous mast cell tumors: morphological grading and survival in 83 dogs. Vet Pathol 21: 469-474, 1984.
7. Simoes JPC, Schoning P and Butine M: Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 31: 637-647, 1994.
8. Turrell JM, Kitchell BE, Miller LM and Theon A: Prognostic factors for radiation treatment of mast cell tumors in 85 dogs. J Am Vet Med Assoc 193: 936-940, 1988.
9. Bostock DE, Crocker J, Harris K and Smith P: Nucleolar organizer regions as indicators of postsurgical prognosis in canine spontaneous mast cell tumors. Br J Cancer 59: 915-918, 1989.
10. Weisse C, Shofer FS and Soremno K: Recurrence rates and sites for grade II canine cutanous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38: 71-73, 2002.
11. Michels GM, Knapp DW, DeNicola DB, Glickman N and Bonney P: Prognosis following surgical excision of canine cutanous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 38: 458-466, 2002.
12. McCaw DL, Miller MA, Ogilvie GE, Withrow SJ, Brewer WG Jr, Klein MK, Bell FW and Anderson SK: Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 8: 406-408, 1994.
13. McCaw DL, Miller MA, Bergman PJ, Withrow SJ, Moore AS, Knapp DW, Fowler D and Johnson JC: Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 11: 375-378, 1997.
14. Thamm DH, Mauldin EA and Vail DM: Prednisone and vinblastine chemotherapy for canine mast cell tumor: 41 cases (1992-1997). J Vet Intern Med 13: 491-497, 1999.
15. Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Engler SJ and Cotter SM: Treatment of canine mast cell tumors with CCNU (Lomustine). J Vet Intern Med 13: 601-605, 1999.
16. Rassnick KM, Gliatto JM, Northrup NC, Chretin JD, Morrison-Colliste K, Cotter SM and Moore AS: Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 18: 75-80, 2004.
17. Gerritson RJ, Teske E, Kraus JS and Rutteman GR: Multi-agent chemotherapy for mast cell tumors in the dog. Vet Quart 20: 28-31, 1998.
18. La Due T, Price GS, Dodge R, Page RL and Threll DE: Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol 39: 57-62, 1998.
19. Ranieri G, Passantino L, Patruno R, Passantino G, Birillo F, Catino A, Mattioli V, Gadaleta C and Ribatti D: The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. One Rep 10: 1189-1193, 2003.
20. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr and Mir LM: Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72: 3694-3700, 1993.
21. Daskalov I, Mudrov N and Peycheva E: Exploring new instrumentation parameters for electrochemotherapy. IEEE Engineering in medicine and biology 18: 62-66, 1999.
22. Tozon N, Sersa G and Cemazar M: Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res 21: 2483-2486, 2001.
23. Spugnini EP and Porrello A: Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 22: 571-580, 2003.
24. Spugnini EP, Citro G and Porrello A: Rational design of new electrodes for electrochemotherapy. J Exp Clin Cancer Res 24: 245-254, 2005.
25. Spugnini EP, Dragonetti E, Vincenzi B, Onori N, Citro G and Baldi A: Pulse mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 16: 23-27, 2006.
26. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
27. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39, 1977.
28. Withrow SJ: Cryosurgery. In: Small Animal Clinical Oncology. Withrow SJ, MacEwen EG (eds.), 3rd Edition, Philadelphia, PA: WB Saunders Co., pp. 77-83, 2001.
29. Al-Sarraf R, Mauldin GN, Patnaik AK and Meleo K: A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 10: 376-378, 1996.
30. Frimberger AE, Moore AS, LaRue SM, Gliatto JM and Bengtson AE: Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 33: 320-324, 1997.